Deciphera Pharmaceuticals - Stock Price History | DCPH

Historical daily share price chart and data for Deciphera Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Deciphera Pharmaceuticals as of October 27, 2021 is 33.87.
  • The all-time high Deciphera Pharmaceuticals stock closing price was 69.93 on December 17, 2019.
  • The Deciphera Pharmaceuticals 52-week high stock price is 68.40, which is 101.9% above the current share price.
  • The Deciphera Pharmaceuticals 52-week low stock price is 26.20, which is 22.6% below the current share price.
  • The average Deciphera Pharmaceuticals stock price for the last 52 weeks is 42.23.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Deciphera Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 54.3131 57.8500 69.4000 33.6300 57.0700 -8.31%
2019 31.7750 22.4800 69.9300 19.9500 62.2400 196.52%
2018 29.1063 25.2100 44.9500 19.0800 20.9900 -7.41%
2017 19.5431 17.6500 24.2000 16.5400 22.6700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.967B $0.042B
Deciphera Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib which are in clinical stage. Deciphera Pharmaceuticals, LLC is based in WALTHAM, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86